ATTO
Attovia Therapeutics, Inc.
There isn't enough reported data to score ATTO yet.
ATTO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate ATTO's fundamentals.
ATTO PE Valuation
ATTO has no meaningful PE right now: it lost money over the past year.
ATTO Forward outlook
There aren't enough analyst estimates for ATTO to show an outlook.
ATTO Earnings Per Share
ATTO Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -4845% | N/A |
ATTO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$18.4M | -$2.5M |
ATTO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +50% | +12.9M shares |
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q2 2025 | — |
| Q1 2025 | — |
ATTO Net Leverage
ATTO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ATTO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.7 | Neutral |
As of the close on Nov 12, 2026: $15.81.
ATTO PE vs Healthcare Sector
ATTO has no meaningful PE right now: it lost money over the past year.
ATTO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.6 | 1.2% above |
ATTO is in an uptrend: it's above all one of its weekly moving averages, and 1.2% above its 8-week average.
ATTO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $20.2 | $15.8 | -22% |
It's down 22% so far in 2026.